These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14028230)

  • 21. [Treatment of coronary circulatory disorders in internal practice with segontin].
    HAMANN E
    Landarzt; 1961 Nov; 37():1277-9. PubMed ID: 13904049
    [No Abstract]   [Full Text] [Related]  

  • 22. [METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN HEALTHY PERSONS AND IN PATIENTS WITH ISCHEMIC HEART DISEASES. II. TECHNICAL METHODS OF RESEARCH AND RESULTS].
    ZOLI A; BRAT A; GIARDINA A
    Riv Crit Clin Med; 1963 Aug; 63():149-73. PubMed ID: 14187838
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of phenylpropyl-diphenylpropyl-amine with other drugs for the treatment of coronary angina and influence on the consumption of nitroglycerin derivatives].
    DI LORENZO S; COSTAGLIOLA A
    Minerva Med; 1963 Apr; 54():1188-93. PubMed ID: 14027552
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of coronary insufficiency].
    NANBA H
    Sogo Rinsho; 1963 Jul; 12():1378-85. PubMed ID: 13937539
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical considerations on the therapeutic action of a new drug with anti-angina action (FPDFPA)].
    LUCCHINI CR; DELLA PORTA P; LUCCHELLI PD
    Minerva Cardioangiol; 1963 Mar; 11():158-65. PubMed ID: 13931431
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on the mode of action of prenylamine (Segontin) and other coronary dilating drugs in man.
    Schmid E; Bachmann K; Krautheim J; Heynen HP
    Indian Heart J; 1968 Apr; 20(2):133-40. PubMed ID: 5738423
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical evaluation of the action of 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine in coronary insufficiency].
    PARON R; DA BROI GL
    Gazz Int Med Chir; 1962 Nov; 66():2496-521. PubMed ID: 13941569
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of Segontin, Persantin and nitroglycerin on the coronary artery. Experimental studies with cinecoronarography.
    DAHL M; KASANEN A; PELTONEN T
    Ann Med Exp Biol Fenn; 1962; 40():423-6. PubMed ID: 14024623
    [No Abstract]   [Full Text] [Related]  

  • 29. [NEW CLINICO-EXPERIMENTAL CONFIRMATIONS ON THE EFFICACY OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN CORONARY DISEASES].
    PINACCI U; RIVALI A
    Minerva Cardioangiol; 1965 May; 13():291-8. PubMed ID: 14333361
    [No Abstract]   [Full Text] [Related]  

  • 30. Prenylamine ("Segontin") in angina of effort.
    ANDERSON DE
    Med J Aust; 1963 Feb; 50(1)():149-50. PubMed ID: 14012827
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the effectiveness of Segontin in heart diseases].
    OSHIMA K; TAKAHASHI S; FUJII A; SASAKI S; KIKUCHI G; KUWABARA T; SHIMIZU A; HAYASHI M
    Chiryo; 1963 Jul; 45():1301-10. PubMed ID: 13940516
    [No Abstract]   [Full Text] [Related]  

  • 32. [Metabolism of prenylamine (Segontin)].
    Palm D; Grobecker H; Fengler H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):185-6. PubMed ID: 4239216
    [No Abstract]   [Full Text] [Related]  

  • 33. [On modern coronary dilators].
    KNABE J
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1963 May; 33():77-82. PubMed ID: 14041704
    [No Abstract]   [Full Text] [Related]  

  • 34. [Suicidal prenylamine-(segontin-) intoxication].
    Beck OA; Hochrein H
    Dtsch Med Wochenschr; 1971 Oct; 96(41):1614-5. PubMed ID: 5098766
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prenylamine (Segontin) in hypertonically-caused myocardial diseases in animal experiments].
    Schmitt G
    Med Klin; 1967 Feb; 62(5):178 passim. PubMed ID: 5590187
    [No Abstract]   [Full Text] [Related]  

  • 36. [STUDIES ON THE MECHANISM OF ACTION OF PHENYLPROPYL-DIPHENYLPROPYLAMINE (SEGONTIN) IN MAN].
    KUSCHKE HJ; ECKMANN F; IDRISS H; BIECK P
    Verh Dtsch Ges Inn Med; 1964; 70():191-5. PubMed ID: 14294216
    [No Abstract]   [Full Text] [Related]  

  • 37. [ON THE ACTION MECHANISM OF PHENYLPROPYL-DIPHENYLPROPYLAMINE (SEGONTIN) IN MAN].
    KUSCHKE HJ; IDRISS H; ECKMANN F
    Klin Wochenschr; 1965 Jun; 43():617-22. PubMed ID: 14308403
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experiences with the coronary drug SA30].
    WALTHER H
    Z Gesamte Inn Med; 1963 May; 18():394-8. PubMed ID: 13998721
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hemodynamic effects after segontin injection].
    MICHEL D
    Bull Off Chambre Synd Med Seine; 1960 Aug; 55():1428-32. PubMed ID: 13770223
    [No Abstract]   [Full Text] [Related]  

  • 40. [PPDPA (PHENYLPROPYLDIPHENYLPROPYLAMINE) IN CORONARY INSUFFICIENCY].
    ASTALDI G; MEARDI G
    Minerva Med; 1965 Jun; 56():2168-73. PubMed ID: 14328098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.